DecisionRx borrows $100 million credit facility from Carlyle

Chicago, Jan. 11 – DecisionRx, Inc. entered into a $100 million credit facility with Carlyle, according to a press release.

The facility is expected to fund lab testing and comprehensive medication reviews by DecisionRx pharmacists.

Carlyle is also receiving an option to acquire 25% of the outstanding equity of the company.

Aon Securities, LLC. served as an adviser to DecisionRx in arranging the financing.

The borrower is an Indianapolis-based technology-enabled health care company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.